597 filings
Page 2 of 30
DEFA14A
s30vi7ujbitkhx
31 Aug 23
Additional proxy soliciting materials
4:09pm
8-K
wr2jpmw
31 Aug 23
Entry into a Material Definitive Agreement
4:07pm
4
b3bqeqim19gd0h
22 Aug 23
Timber Pharmaceuticals / John Koconis ownership change
7:46pm
4
810l25
22 Aug 23
Timber Pharmaceuticals / Alan Mendelsohn ownership change
7:45pm
4
cp8iguncwk
22 Aug 23
Timber Pharmaceuticals / Joseph Lucchese ownership change
7:43pm
DEFA14A
uxybz i7x4u3z7
21 Aug 23
Additional proxy soliciting materials
8:12am
8-K
cp9yt3 zhdiey870wc
21 Aug 23
Timber Pharmaceuticals to be Acquired by LEO Pharma
8:11am
NT 10-Q
lg2q1dnycla9
14 Aug 23
Notice of late quarterly filing
4:29pm
S-8
udhbodh9msyq qbb5o
2 Aug 23
Registration of securities for employees
5:10pm
8-K
lnbi1cx1vwcfj49p35b7
3 Jul 23
Timber Pharmaceuticals Discloses Communication From NYSE American
4:10pm
8-K
913mjklpe8rm6w6xhnqr
29 Jun 23
Regulation FD Disclosure
4:03pm
8-K
u7htiko7pb
23 Jun 23
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
h0ogw mn3wd4yubkc
20 Jun 23
Timber Pharmaceuticals to Present Interim Analyses from Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis
8:26am
8-K
zga8gj4ink
5 Jun 23
Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001
8:28am
8-K
1gd8e3w
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:34pm
8-K
q08z25
15 May 23
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results
4:25pm
ARS
g4ex13z7b5qfv5i4
1 May 23
Annual report to shareholders
4:32pm